Table 3.
Covariate analysis of overall survival from time of diagnosis for patients with a documented relapse during first remission.
| Covariate | Level | N | Hazard ratio (95% confidence interval) | p Value |
|---|---|---|---|---|
| Age at diagnosis | Risk per year | 98 | 1.03 (1.01–1.06) | .023 |
| Gender | Female | 20 | 1.10 (0.56–2.14) | .789 |
| Male | 79 | |||
| Ethnicity | White | 50 | 1.28 (0.37–4.45) | .692 |
| Non-white | 6 | |||
| Splenomegaly | Yes | 48 | 1.72 (0.80–3.69) | .164 |
| No | 20 | |||
| Bulky disease (any lymph node >5 cm) | Yes | 24 | 0.74 (0.34–1.57) | .426 |
| No | 35 | |||
| Ki67% | >30% | 15 | 0.61 (0.18–2.10) | .433 |
| MIPI risk group | ≤30% High |
9 9 |
2.02 (0.70–5.82) | .193 |
| Intermediate | 15 | 0.95 (0.33–2.70) | .918 | |
| Low | 13 | |||
| Relapse diagnosis type | Surveillance | 37 | 0.74 (0.40–1.35) | .327 |
| Non-surveillance | 62 |
p< .05 are marked in bold.